Monograph Title | Section Sort descending | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
DOXYCYCLINE HYCLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change 480.13 to: 480.90 |
PANTOPRAZOLE SODIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 3388 | 24-Apr-2020 | 1-May-2020 | NA | NA | In USP Pantoprazole Related Compound E RS: Change C34H28F4N6O8S2 764.74 to: C32H28F4N6O8S2 764.72 |
ARGATROBAN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 346 | 27-Apr-2018 | 1-May-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Argatroban Related Compound B RS: Change Ethyl (2R,4R)-1-[N8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate hydrochloride. C15H28N6O5 ∙ HCl 408.88 to: … Read More |
METHYLENE BLUE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Azure B RS: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
CARBAMAZEPINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Carbamazepine Related Compound A RS: Change 238.28 to: 238.29 AND In USP Carbamazepine Related Compound B RS: Change 193.24 to: 193.25 AND In USP 9-Methylacridine RS: Change 193.24 to: 193.25 |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
AMITRIPTYLINE HYDROCHLORIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 263 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Amitriptyline Related Compound B RS: Change 295.42 to: 295.43 |
MEPIVACAINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 2580 | 28-Sep-2018 | 1-Oct-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Line 2 of Bupivacaine Related Compound B: Change N-(2,6-Dimethylphenyl)piperidine-2-carboxamide. C14H20N2O 232.32 to: N-(2,6-Dimethylphenyl)piperidine-2-carboxamide hydrochloride. C14… Read More |
FEXOFENADINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 1828 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | In USP Fexofenadine Related Compound A RS: Change Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl. to: 2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid; Also known as Benzeneacetic… Read More |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Econazole Related Compound C RS: Change 1-(4-Chlorobenzyl)-3-{2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazol-3-ium nitrate (salt). C25H21Cl14N3O4 569.… Read More |
TRYPTOPHAN | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Tryptophan Related Compound A RS: Change 3,3′-[Ethylidenebis(1H-indole-1,3-diyl)]bis[2S)-2-aminopropanoic]acid. C24H26N4O4 432.49 to: (2S,2'S)-3,3'-[Ethane-1,1-diylbis(1H-… Read More |
METARAMINOL BITARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP Metaraminol Enantiomer RS: Change 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol. C9H13NO2 167.21 to: 3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate. C9H… Read More |
METHOTREXATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Methotrexate System Suitability Mixture RS: Change C22H26N8O5 · HCl 518.95 to: C22H26N8O5 · xHCl |
ESZOPICLONE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official August 01, 2017) | Online | 26-Jan-2018 | 1-Feb-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Eszopiclone Related Compound A RS: Change 6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide. C17H17ClN6O4 404.81 to: [Note—This… Read More |
ESZOPICLONE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP40–NF35 | 4090 | 26-Jan-2018 | 1-Feb-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Eszopiclone Related Compound A RS: Change 6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide. C17H17ClN6O4 404.81 to: [Note—This… Read More |
TIMOLOL MALEATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP40–NF35 | 8416 | 26-Jan-2018 | 1-Feb-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Timolol Related Compound A RS: Change (R)-1-(tert-Butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-ol. C13H24N4O3S 316.42 to: (R)-1-(tert-Butylamino)-3-(4-morpholino-1,2,… Read More |
TIMOLOL MALEATE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP40–NF35 | 6481 | 26-Jan-2018 | 1-Feb-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 3 of USP Timolol Related Compound D RS: Change C6H9N7O4S to: C6H9N3O2S |
PAROXETINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP40–NF35 | Online | 23-Feb-2018 | 1-Mar-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 1 of USP Paroxetine Related Compound F RS: Change trans(−)-1-Methyl-3-[1,3-benzodioxol-5-yloxy)methyl]-4-(fluorophenyl)piperidine. to: (3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine. |
RIVASTIGMINE TARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 5213 | 25-Sep-2015 | 1-Oct-2015 | USP40–NF35 | First Supplement to USP39–NF34 | Line 2 of USP Rivastigmine Related Compound B RS: Change N,N-Dimethylcarbamic acid-3-[1-(dimethylamino)ethyl]phenyl ester. to: (RS)‐3‐[1‐(Dimethylamino)ethyl]phenyl dimethylcarbamate. |
HYDROXYZINE PAMOATE ORAL SUSPENSION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 3817 | 25-Sep-2015 | 1-Oct-2015 | USP40–NF35 | First Supplement to USP39–NF34 | Delete USP Hydroxyzine Hydrochloride RS |
RIVASTIGMINE TARTRATE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 5215 | 25-Sep-2015 | 1-Oct-2015 | USP40–NF35 | First Supplement to USP39–NF34 | Line 2 of USP Rivastigmine Related Compound B RS: Change N,N-Dimethylcarbamic acid-3-[1-(dimethylamino)ethyl]phenyl ester. to: (RS)‐3‐[1‐(Dimethylamino)ethyl]phenyl dimethylcarbamate. |
ROPIVACAINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 5225 | 25-Sep-2015 | 1-Oct-2015 | USP40–NF35 | First Supplement to USP39–NF34 | Line 2 of USP Ropivacaine Related Compound B RS: Change (R)-ropivacaine hydrochloride monohydrate; (R)-(−)-1-propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)-amide hydrochloride monohydrate. to: (R)-Ropivacaine hydrochloride monohydrate; (R)-(+)-1-… Read More |
RIVASTIGMINE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 5212 | 25-Sep-2015 | 1-Oct-2015 | USP40–NF35 | First Supplement to USP39–NF34 | Line 2 of USP Rivastigmine Related Compound B RS: Change Nor impurity; (S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate. to: Nor impurity (racemic mixture); (RS)‐3‐[1‐(Dimethylamino)ethyl]phenyl dimethylcarbamate. |
CEFADROXIL CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP37–NF32 | 6604 | 25-Jul-2014 | 1-Aug-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Line 2 of USP Cefadroxil Related Compound I RS: Change (6R,7R)-7-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate. to: (6R,7R)-7-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido… Read More |
RIVASTIGMINE TARTRATE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP37–NF32 | 4616 | 27-Mar-2015 | 1-Apr-2015 | USP39–NF34 | USP39–NF34 | Line 2 of USP Rivastigmine Related Compound A RS: Change Di-p-toluoyl-D-(+)-tartaric acid monohydrate. C20H20O9 404.37 to: (+)-Di-(p-toluoyl)-D-tartaric acid. C20H18O8 386.35 |
RISPERIDONE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP37–NF32 | 7240 | 30-Jan-2015 | 1-Feb-2015 | USP39–NF34 | Second Supplement to USP38–NF33 | Line 2 of USP Risperidone Related Compound G RS: Change 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one. C23H28FN3O3 413.49 to: 3-[2-[4-(4-… Read More |
STERILE WATER FOR INHALATION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP37–NF32 | 5174 | 26-Sep-2014 | 1-Oct-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Add: USP 1,4-Benzoquinone RS AND USP Sucrose RS |
PAROXETINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 4765 | 30-Jan-2015 | 1-Feb-2015 | USP39–NF34 | Second Supplement to USP38–NF33 | Lines 4 and 7 of USP Paroxetine System Suitability Mixture A RS: Change hydrochloride (3 S-trans) to: hydrochloride (3S-trans) |
METHYLPHENIDATE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 4345 | 29-May-2015 | 1-Jun-2015 | USP39–NF34 | USP39–NF34 | Line 3 of USP Methylphenidate Related Compound A RS: Change 255.75 to: 255.74 |
ATROPINE SULFATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 2325 | 30-Jan-2015 | 1-Feb-2015 | USP39–NF34 | Second Supplement to USP38–NF33 | Line 2 of USP Hyoscyamine Related Compound A RS: Change Norhyoscyamine sulfate; (1R,3r,5S)-8-azabicyclo [3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenylpropanoate.C16H21NO3 275.34 to: Norhyoscyamine sulfate; (1R,3r,5… Read More |
VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official April 01, 2014) | Online | 30-Jan-2015 | 1-Feb-2015 | USP39–NF34 | Second Supplement to USP38–NF33 | Line 2 of USP Valsartan Related Compound B RS: Change (S-N-Butyryl-N-([2′-(1H-tetrazole-5-yl)biphen-4-yl]methyl)-valine. to: N-Butyryl-N-{[2′-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine. |
STERILE WATER FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP37–NF32 | 5175 | 26-Sep-2014 | 1-Oct-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Add: USP 1,4-Benzoquinone RS AND USP Sucrose RS |
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP38–NF33 | 4348 | 29-May-2015 | 1-Jun-2015 | USP39–NF34 | USP39–NF34 | Line 3 of USP Methylphenidate Related Compound A RS: Change 255.75 to: 255.74 |
TERBINAFINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP37–NF32 | 6704 | 25-Jul-2014 | 1-Aug-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Line 2 of USP Terbinafine Related Compound A RS: Change N-Methyl-C-(naphthalen-1-yl)methanamine. to: N-Methyl-C-(naphthalen-1-yl)methanamine hydrochloride. AND Line 2 of USP Terbinafine Related Compound B RS: Change (2Z)-N,6,6-Trimethyl-… Read More |
STERILE WATER FOR IRRIGATION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP37–NF32 | 5175 | 26-Sep-2014 | 1-Oct-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Add: USP 1,4-Benzoquinone RS AND USP Sucrose RS |
RISPERIDONE ORAL SOLUTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP37–NF32 | Online | 25-Jul-2014 | 1-Aug-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Line 2 of USP Risperidone Related Compounds Mixture RS: Change Contains a mixture of the following four compounds: 98.9% of Risperidone. 0.5% of Risperidone cis-N-oxide: cis-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4… Read More |
FENTANYL | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP37–NF32 | Online | 21-Nov-2014 | 1-Dec-2014 | USP39–NF34 | Second Supplement to USP38–NF33 | Delete USP Fentanyl Related Compound C RS AND Delete USP Fentanyl Related Compound F RS |
RIVASTIGMINE TARTRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP37–NF32 | Online | 27-Mar-2015 | 1-Apr-2015 | USP39–NF34 | USP39–NF34 | Line 2 of USP Rivastigmine Related Compound A RS: Change Di-p-toluoyl-D-(+)-tartaric acid monohydrate. C20H20O9 404.37 to: (+)-Di-(p-toluoyl)-D-tartaric acid. C20H18O8 386.35 |
TRAZODONE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP37–NF32 | 6708 | 21-Nov-2014 | 1-Dec-2014 | USP39–NF34 | Second Supplement to USP38–NF33 | Line 2 of USP Trazodone Related Compound D RS: Change (2-{3-[4-(4-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-α]pyridin-3(2H)-one hydrochloride. to: 2-{3-[4-(3-Bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-α]pyridin-3(2H)-one hydrochloride. |
LEVALBUTEROL HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP37–NF32 | 3513 | 25-Jul-2014 | 1-Aug-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Line 2 of USP Levalbuterol Related Compound H RS: Change 4-[2-(tert-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol. C14H23NO3 253.34 to: 4-[2-(tert-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol acetate. C14H… Read More |
AMINOPHYLLINE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP40–NF35 | 2735 | 27-Jan-2017 | 1-Feb-2017 | USP41–NF36 | Second Supplement to USP40–NF35 | Line 2 of USP Theophylline Related Compound D RS: Change N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide. C6H10N4O 154.17 to: Theophyllidine; N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride… Read More |
TROSPIUM CHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP39–NF34 | 6287 | 27-May-2016 | 1-Jun-2016 | USP40–NF35 | USP40–NF35 | Line 3 of USP Trospium Chloride Related Compound C RS:Change (1R,3r,5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1′-pyrrolidinium] chloride. to: (1R,3r,5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1′-pyrrolidinium] chloride, or (1R… Read More |
MYCOPHENOLATE MOFETIL FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP39–NF34 | 4961 | 31-Mar-2017 | 1-Apr-2017 | USP41–NF36 | USP41–NF36 | Line 5 of Mycophenolate Mofetil Related Compound A RS: Change C23H31NO7 to: C22H29NO7 |
NEOTAME | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP40–NF35 | 8485 | 28-Jul-2017 | 1-Aug-2017 | USP42–NF37 | First Supplement to USP41–NF36 | Line 2 of USP Neotame Related Compound A RS: Change N-[3,3-Dimethylbutyl)-L-α-aspartyl]-L-phenylalanine. to: N-[N-(3,3-Dimethylbutyl)-L-α-aspartyl]-L-phenylalanine. |
ECHINACEA PALLIDA | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP37–NF32 | 5353 | 30-May-2014 | 1-Jun-2014 | USP38–NF33 | USP38–NF33 | Line 5: Change USP Powdered Echinacea purpurea Extract RS to: USP Powdered Echinacea pallida Extract RS |
NICOTINE POLACRILEX | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP39–NF34 | 5061 | 27-May-2016 | 1-Jun-2016 | USP40–NF35 | USP40–NF35 | Add USP Polacrilex Resin RS |
AMINOPHYLLINE INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP40–NF35 | 2737 | 27-Jan-2017 | 1-Feb-2017 | USP41–NF36 | Second Supplement to USP40–NF35 | Line 2 of USP Theophylline Related Compound D RS: Change N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide. C6H10N4O 154.17 to: Theophyllidine; N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride… Read More |
KETOROLAC TROMETHAMINE INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP39–NF34 | 4468 | 29-Jul-2016 | 1-Aug-2016 | USP41–NF36 | First Supplement to USP40–NF35 | Line 4 of USP Ketorolac Related Compound A RS: Change 358.15 to: 358.39 AND Line 3 of USP Ketorolac Related Compound B RS: Change 227.09 to: 227.26 AND Line 3 of USP Ketorolac Related Compound C RS: Change 225.09 to: 225.24 AND Line 3 of USP Ketorolac… Read More |
CYCLOBENZAPRINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP39–NF34 | 3333 | 18-Nov-2016 | 1-Dec-2016 | USP41–NF36 | Second Supplement to USP40–NF35 | Line 2 of USP Cyclobenzaprine Related Compound B RS: Change 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine. C19H19N 261.36 to: 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine… Read More |
Carisoprodol Tablets | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP35–NF30 | 5921 | 30-Nov-2012 | 1-Dec-2012 | USP37–NF32 | Second Supplement to USP36–NF31 | Line 5: At end of USP Reference Standards, add USP Meprobamate RS |